|
HY-153832-10mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153832-100mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153832-25mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153832-5mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-153832-50mg
|
MedChemexpress LLC
|
MSU-42011 [CAS 2456434-36-7]
|
|
Cancer-programmed cell death
|
|
|
HY-P72273-10ug
|
MedChemexpress LLC
|
Mu SK, Human (P.pastoris, His)
|
|
|
|
|
HY-P72273-2ug
|
MedChemexpress LLC
|
Mu SK, Human (P.pastoris, His)
|
|
|
|
|
HY-P72273-50ug
|
MedChemexpress LLC
|
Mu SK, Human (P.pastoris, His)
|
|
|
|
|
HY-114544A-10mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-100mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-5mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-50mg
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2]
|
|
COVID-19-immunoregulation
|
|
|
HY-114544A-1mL
|
MedChemexpress LLC
|
N-3-oxo-dodecanoyl-L-homoserine lactone [CAS 168982-69-2] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-14463-10mg
|
MedChemexpress LLC
|
Onalespib [CAS 912999-49-6]
|
|
Cancer-programmed cell death
|
|
|
HY-14463-100mg
|
MedChemexpress LLC
|
Onalespib [CAS 912999-49-6]
|
|
Cancer-programmed cell death
|
|
|
HY-14463-5mg
|
MedChemexpress LLC
|
Onalespib [CAS 912999-49-6]
|
|
Cancer-programmed cell death
|
|
|
HY-14463-50mg
|
MedChemexpress LLC
|
Onalespib [CAS 912999-49-6]
|
|
Cancer-programmed cell death
|
|
|
HY-14463-1mL
|
MedChemexpress LLC
|
Onalespib [CAS 912999-49-6] (10mM in DMSO)
|
|
Cancer-programmed cell death
|
|
|
HY-144767-10mg
|
MedChemexpress LLC
|
PA3552-IN-1 [CAS 1008121-12-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-144767-100mg
|
MedChemexpress LLC
|
PA3552-IN-1 [CAS 1008121-12-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-144767-25mg
|
MedChemexpress LLC
|
PA3552-IN-1 [CAS 1008121-12-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-144767-5mg
|
MedChemexpress LLC
|
PA3552-IN-1 [CAS 1008121-12-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-144767-50mg
|
MedChemexpress LLC
|
PA3552-IN-1 [CAS 1008121-12-7]
|
|
COVID-19-immunoregulation
|
|
|
HY-144767-1mL
|
MedChemexpress LLC
|
PA3552-IN-1 [CAS 1008121-12-7] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-N3584-10mg
|
MedChemexpress LLC
|
Paris saponin VII [CAS 68124-04-9]
|
|
Cancer-Kinase/protease
|
|
